Indeed, tumor microenvironmental signals, such as tumor antigens, cytokines (e.g., TGF-β) and metabolic factors (e.g., lactate and lipid metabolites), can drive naïve CD4+ T cell differentiation into Tregs, which are immunosuppressive phenotypes [61]. The gene discussed is TGFB1; the disease is neoplasm.